Bis-styrylpyridine and bis-styrylbenzene derivatives as inhibitors for Aβ fibril formation
摘要:
New bis-styrylpyridine and bis-styrylbenzene derivatives were designed and synthesized. These 34 compounds were evaluated by A beta fibril formation inhibitory assay using thioflavin T as a dye (named ThT assay). Most of them showed excellent inhibitory activities for A beta fibril formation at IC50 of 0.1-2.7 mu M which is comparable to curcumin (IC50 of 0.8 mu M). Among them, nine compounds were screened for their cytotoxicities on HT-22 cell by MTT assay at 1, 10, and 50 mu M. In particular, 1-7 and II-2 exhibited the best combination of inhibitory activity and compound cytotoxicity. (c) 2006 Elsevier Ltd. All rights reserved.
Bis-styrylpyridine and bis-styrylbenzene derivatives as inhibitors for Aβ fibril formation
摘要:
New bis-styrylpyridine and bis-styrylbenzene derivatives were designed and synthesized. These 34 compounds were evaluated by A beta fibril formation inhibitory assay using thioflavin T as a dye (named ThT assay). Most of them showed excellent inhibitory activities for A beta fibril formation at IC50 of 0.1-2.7 mu M which is comparable to curcumin (IC50 of 0.8 mu M). Among them, nine compounds were screened for their cytotoxicities on HT-22 cell by MTT assay at 1, 10, and 50 mu M. In particular, 1-7 and II-2 exhibited the best combination of inhibitory activity and compound cytotoxicity. (c) 2006 Elsevier Ltd. All rights reserved.
[EN] COMPOUND FOR INHIBITING THE FORMATION OF BETA-AMYLOID FIBRIL, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME<br/>[FR] COMPOSÉ POUR INHIBER LA FORMATION D'UNE FIBRILLE DE BÊTA-AMYLOÏDE, SA PRÉPARATION ET COMPOSITION PHARMACEUTIQUE LE COMPRENANT
申请人:KOREA INST SCI & TECH
公开号:WO2008030072A1
公开(公告)日:2008-03-13
[EN] The present invention relates to a novel compound which is effective in inhibiting the formation of beta-amyloid fibril in the brain, a method for preparing same, and a pharmaceutical composition comprising same as an active ingredient. [FR] La présente invention porte sur un nouveau composé qui est efficace pour inhiber la formation d'une fibrille de bêta-amyloïde dans le cerveau, sur son nouveau procédé de préparation et sur la composition pharmaceutique le comprenant et utile comme ingrédient actif.